Literature DB >> 27405110

An Overview on Predictive Biomarkers of Testicular Germ Cell Tumors.

Paolo Chieffi1.   

Abstract

Testicular germ cell tumors (TGCTs) are frequent solid malignant tumors and cause of death in men between 20-40 years of age. Genetic and environmental factors play an important role in the origin and development of TGCTs. Although the majority of TGCTs are responsive to chemotherapy, about 20% of patient presents incomplete response or tumors relapse. In addition, the current treatments cause acute toxicity and several chronic collateral effects, including sterility. The present mini-review collectively summarize the most recent findings on the new discovered molecular biomarkers such as tyrosine kinases, HMGAs, Aurora B kinase, and GPR30 receptor predictive of TGCTs and as emerging new possible molecular targets for therapeutic strategies. J. Cell. Physiol. 232: 276-280, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27405110     DOI: 10.1002/jcp.25482

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

1.  CFIm25 in Solid Tumors: Current Research Progress.

Authors:  Xiaojie Sun; Ji Li; Xun Sun; Wanqi Liu; Xiangwei Meng
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

2.  c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors.

Authors:  Katia Corano Scheri; Erica Leonetti; Luigi Laino; Vincenzo Gigantino; Luisa Gesualdi; Paola Grammatico; Mariano Bizzari; Renato Franco; J Wolter Oosterhuis; Hans Stoop; Leendert H J Looijenga; Giulia Ricci; Angela Catizone
Journal:  Oncotarget       Date:  2018-08-07

Review 3.  Glyoxalases in Urological Malignancies.

Authors:  Cinzia Antognelli; Vincenzo Nicola Talesa
Journal:  Int J Mol Sci       Date:  2018-01-31       Impact factor: 5.923

4.  CSE1L participates in regulating cell mitosis in human seminoma.

Authors:  Chunyan Liu; Jiajing Wei; Kang Xu; Xiaosong Sun; Huiping Zhang; Chengliang Xiong
Journal:  Cell Prolif       Date:  2018-11-28       Impact factor: 6.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.